ImageFortis Healthcare, a privately owned hospitals chain promoted by the Singh family, who previously owned Ranbaxy Laboratories, has forayed into the International healthcare market for the first time. Fortis, through one of its wholly owned subsidiary, has joined hands with a diversified Mauritian Industrial Group CIEL, through its subsidiary Novelife, to acquire jointly a controlling stake in Mauritius’s largest private hospital, “Clinique Darné,” now rechristened Fortis Clinique Darné.

 

Fortis Clinique Darné is said to be one of the most modern medical centers in Mauritius, with hi-tech facilities and offering wide range of general and specialized medical services in a caring and friendly environment. Fortis plans to use this strategic entry into Mauritius to spread its footprints in developed markets and replicate its successful business model.

Fortis has also taken over the operations and management of the hospital and plans to develop the hospital into a large super specialty hospital in the region. Fortis Clinique Darné is said to have an adequate potential for growth keeping in mind its six acre property and the size of the market in Mauritius and neighboring countries.

ortis has also taken over the operations and management of the hospital and plans to develop the hospital into a large super specialty hospital in the region. Fortis Clinique Darné is said to have an adequate potential for growth keeping in mind its six acre property and the size of the market in Mauritius and neighboring countries.Mr Shivinder Mohan Singh, CEO, Fortis Healthcare said, “This deal marks Fortis’s first foray internationally. We are very excited about this opportunity to work with our partners to develop tertiary level quality healthcare in the Mascareignes region. This deal is a clear indication of India’s rise in the International healthcare space and we are privileged to be leading that transformation.”

According to the company, Mauritius Healthcare is dominated by public sector hospitals, community and health centers that are under-equipped in terms of infrastructure and medical skills. Many Mauritians have to travel to other countries for high end treatment.

This would enable Fortis to leverage Medical Value Travel by creating a gateway to Fortis Network of hospitals within India, as also develop Fortis Clinique Darné as a hub for Medical Tourism in Mauritius. Mauritius, with nine lakhs tourists visiting every year, is said to present ample opportunity to promote medical tourism for elective procedures and minor surgeries.

Fortis, through this acquisition will get a seamless entry into Mauritius where majority of the population is of Indian origin. Fortis Clinique Darné is evenly poised to leverage Fortis’ expertise and experience of operating super specialty hospitals to upgrade the clinical level of its medical program to tertiary care and grow significantly in size. Fortis, with its wide network of telemedicine in African countries, would also help evolve Fortis Clinique Darné as a super specialty center for neighboring countries.